SUBSCRIBE
SUBSCRIBE
News   Business

Idenix Pharmaceuticals, Inc. Says Novartis Pharma AG (JOBS) Not to License Hepatitis C Drug

October 30, 2009 | 
1 min read

Reuters -- Idenix Pharmaceuticals Inc (IDIX.O) said Novartis Pharma AG (NOVN.VX) has decided not to exercise its option to license Idenix’s hepatitis C drug, sending Idenix shares down 20 percent.

Alliances
MORE ON THIS TOPIC
cutting off a row of people into pieces
Layoffs
Editas Axes 60% of Staff, Sickle Cell Therapy After Failing to Find Partner
December 13, 2024
 · 
2 min read
 · 
Tristan Manalac
Illustration of cardboard box filled with office supplies, a computer keyboard, lamp, and a potted plant
Layoff Tracker
Bavarian, BenevolentAI, Chroma Medicine and Nvelop Therapeutics Cut Staff
December 12, 2024
 · 
205 min read
 · 
BioSpace Editorial Staff
Podcast
Highlights From ASH, Lilly and Novo’s Manufacturing Boon, Momentum in Neuro, More
December 11, 2024
 · 
1 min read
 · 
Heather McKenzie
Group Of Employees Being Fired By Their Company.
Layoffs
Carisma Therapeutics to Cut 34% of Staff, Reprioritize Pipeline
December 10, 2024
 · 
2 min read
 · 
Angela Gabriel